Smith & Nephew SNATS (NYSE:SNN) Sees Strong Trading Volume – What’s Next?

Smith & Nephew SNATS, Inc. (NYSE:SNN) shares saw strong trading volume on Thursday . 1,714,084 shares traded hands during trading, an increase of 54% from the previous session’s volume of 1,114,004 shares.The stock last traded at $31.4450 and had previously closed at $30.80.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Weiss Ratings lowered Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, June 11th. Canaccord Genuity Group dropped their target price on Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a research note on Monday, May 11th. Sanford C. Bernstein set a $31.85 price target on Smith & Nephew SNATS in a research note on Monday, May 11th. Wall Street Zen upgraded Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Finally, Kepler Capital Markets downgraded shares of Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research note on Thursday, June 4th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $30.93.

Smith & Nephew SNATS Stock Up 2.1%

The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.25 and a current ratio of 2.57. The stock has a 50-day simple moving average of $30.19 and a 200-day simple moving average of $32.38.

Institutional Trading of Smith & Nephew SNATS

Institutional investors and hedge funds have recently bought and sold shares of the business. Garner Asset Management Corp purchased a new stake in Smith & Nephew SNATS during the fourth quarter worth approximately $27,000. Arax Advisory Partners lifted its stake in shares of Smith & Nephew SNATS by 142.6% during the fourth quarter. Arax Advisory Partners now owns 968 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 569 shares in the last quarter. Advisors Asset Management Inc. purchased a new stake in shares of Smith & Nephew SNATS during the fourth quarter valued at approximately $36,000. Caitong International Asset Management Co. Ltd purchased a new position in Smith & Nephew SNATS in the 3rd quarter valued at about $41,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Smith & Nephew SNATS during the 4th quarter valued at approximately $43,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.